-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$23.3359.58% Upside
ARS Pharmaceuticals, Inc. Frequently Asked Questions
-
What analysts cover ARS Pharmaceuticals, Inc.?
ARS Pharmaceuticals, Inc. has been rated by research analysts at Cantor Fitzgerald, Raymond James, Leerink Partners in the past 90 days.